125 related articles for article (PubMed ID: 38271566)
21. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
22. The keratin 17/YAP/IL6 axis contributes to E-cadherin loss and aggressiveness of diffuse gastric cancer.
Li M; Rao X; Cui Y; Zhang L; Li X; Wang B; Zheng Y; Teng L; Zhou T; Zhuo W
Oncogene; 2022 Feb; 41(6):770-781. PubMed ID: 34845376
[TBL] [Abstract][Full Text] [Related]
23. Down-regulated miRs specifically correlate with non-cardial gastric cancers and Lauren's classification system.
Lorenzon L; Cippitelli C; Avantifiori R; Uccini S; French D; Torrisi MR; Ranieri D; Mercantini P; Canu V; Blandino G; Cavallini M
J Surg Oncol; 2017 Aug; 116(2):184-194. PubMed ID: 28475823
[TBL] [Abstract][Full Text] [Related]
24. The Wnt/β-catenin and PI3K/Akt signaling pathways promote EMT in gastric cancer by epigenetic regulation via H3 lysine 27 acetylation.
Song Y; Li ZX; Liu X; Wang R; Li LW; Zhang Q
Tumour Biol; 2017 Jul; 39(7):1010428317712617. PubMed ID: 28671020
[TBL] [Abstract][Full Text] [Related]
25. The beginning of the era of precision medicine for gastric cancer with fibroblast growth factor receptor 2 aberration.
Ooki A; Yamaguchi K
Gastric Cancer; 2021 Nov; 24(6):1169-1183. PubMed ID: 34398359
[TBL] [Abstract][Full Text] [Related]
26. Relationship between Helicobacter pylori tyrosine-phosphorylated CagA-related markers and the development of diffuse-type gastric cancers: a case-control study.
Wada Y; Ito M; Takata S; Tanaka S; Yoshihara M; Chayama K
Digestion; 2010; 82(1):10-7. PubMed ID: 20145403
[TBL] [Abstract][Full Text] [Related]
27. Synaptotagmin 11 scaffolds MKK7-JNK signaling process to promote stem-like molecular subtype gastric cancer oncogenesis.
Kim BK; Kim DM; Park H; Kim SK; Hwang MA; Lee J; Kang MJ; Byun JE; Im JY; Kang M; Park KC; Yeom YI; Kim SY; Jung H; Kweon DH; Cheong JH; Won M
J Exp Clin Cancer Res; 2022 Jun; 41(1):212. PubMed ID: 35768842
[TBL] [Abstract][Full Text] [Related]
28. In vivo CRISPR-Cas9 knockout screening using quantitative PCR identifies thymosin beta-4 X-linked that promotes diffuse-type gastric cancer metastasis.
An HW; Kim SY; Kwon JW; Seok SH; Woo SH; Kim DY; Park JW
Mol Carcinog; 2021 Sep; 60(9):597-606. PubMed ID: 34081824
[TBL] [Abstract][Full Text] [Related]
29. Identification of genomic aberrations associated with lymph node metastasis in diffuse-type gastric cancer.
Choi JH; Kim YB; Ahn JM; Kim MJ; Bae WJ; Han SU; Woo HG; Lee D
Exp Mol Med; 2018 Apr; 50(4):1-11. PubMed ID: 29622765
[TBL] [Abstract][Full Text] [Related]
30. ITGB1-mediated molecular landscape and cuproptosis phenotype induced the worse prognosis in diffuse gastric cancer.
Zhu X; Chen H; Li H; Ren H; Ye C; Xu K; Liu J; Du F; Zhang Z; Liu Y; Xie X; Wang M; Ma T; Chong W; Shang L; Li L
Front Oncol; 2023; 13():1115510. PubMed ID: 37007126
[TBL] [Abstract][Full Text] [Related]
31. Quantitative phosphoproteomics reveals molecular pathway network alterations in human early-stage primary hepatic carcinomas: potential for 3P medical approach.
Zhang Y; Li N; Yang L; Jia W; Li Z; Shao Q; Zhan X
EPMA J; 2023 Sep; 14(3):477-502. PubMed ID: 37605650
[TBL] [Abstract][Full Text] [Related]
32. Mina53, a novel molecular marker for the diagnosis and prognosis of gastric adenocarcinoma.
Xing J; Wang K; Liu PW; Miao Q; Chen XY
Oncol Rep; 2014 Feb; 31(2):634-40. PubMed ID: 24337011
[TBL] [Abstract][Full Text] [Related]
33. [Clinicopathologic features of gastric adenocarcinoma based on the revised Lauren's classification].
Li Y; Xue XW; Luo YF; Wu HW; Chen J; Zhou WX
Zhonghua Bing Li Xue Za Zhi; 2018 Jul; 47(7):486-491. PubMed ID: 29996311
[No Abstract] [Full Text] [Related]
34. Circulating microRNAs as biomarkers for early detection of diffuse-type gastric cancer using a mouse model.
Rotkrua P; Shimada S; Mogushi K; Akiyama Y; Tanaka H; Yuasa Y
Br J Cancer; 2013 Mar; 108(4):932-40. PubMed ID: 23385731
[TBL] [Abstract][Full Text] [Related]
35. Methylation silencing of ULK2 via epithelial-mesenchymal transition causes transformation to poorly differentiated gastric cancers.
Motoo I; Nanjo S; Ando T; Yamashita S; Ushijima T; Yasuda I
Gastric Cancer; 2022 Mar; 25(2):325-335. PubMed ID: 34554345
[TBL] [Abstract][Full Text] [Related]
36. Phosphoproteomics of Retinoblastoma: A Pilot Study Identifies Aberrant Kinases.
Selvan LDN; Danda R; Madugundu AK; Puttamallesh VN; Sathe GJ; Krishnan UM; Khetan V; Rishi P; Prasad TSK; Pandey A; Krishnakumar S; Gowda H; Elchuri SV
Molecules; 2018 Jun; 23(6):. PubMed ID: 29914080
[TBL] [Abstract][Full Text] [Related]
37. MTMR2 promotes invasion and metastasis of gastric cancer via inactivating IFNγ/STAT1 signaling.
Jiang L; Liu JY; Shi Y; Tang B; He T; Liu JJ; Fan JY; Wu B; Xu XH; Zhao YL; Qian F; Cui YH; Yu PW
J Exp Clin Cancer Res; 2019 May; 38(1):206. PubMed ID: 31113461
[TBL] [Abstract][Full Text] [Related]
38. Tumorigenic mechanisms of estrogen and Helicobacter pylori cytotoxin-associated gene A in estrogen receptor α-positive diffuse-type gastric adenocarcinoma.
Kang S; Park M; Cho JY; Ahn SJ; Yoon C; Kim SG; Cho SJ
Gastric Cancer; 2022 Jul; 25(4):678-696. PubMed ID: 35391613
[TBL] [Abstract][Full Text] [Related]
39. Diverse proteomic alterations in gastric adenocarcinoma.
He QY; Cheung YH; Leung SY; Yuen ST; Chu KM; Chiu JF
Proteomics; 2004 Oct; 4(10):3276-87. PubMed ID: 15378696
[TBL] [Abstract][Full Text] [Related]
40. Transferrin receptor 1 promotes the fibroblast growth factor receptor-mediated oncogenic potential of diffused-type gastric cancer.
Shirakihara T; Yamaguchi H; Kondo T; Yashiro M; Sakai R
Oncogene; 2022 Apr; 41(18):2587-2596. PubMed ID: 35338344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
